(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 9.59%658.65M | 14.26%1.3B | 11.68%601M | -2.54%1.14B | --538.14M | 56.22%1.17B | -30.34%749.76M | 5.15%1.08B | 1.91%546.81M | 30.59%1.02B |
Operating income | 9.59%658.65M | 14.26%1.3B | 11.68%601M | -2.54%1.14B | 538.14M | 56.22%1.17B | -30.34%749.76M | 5.15%1.08B | 1.91%546.81M | 30.59%1.02B |
Cost of sales | -11.32%-449.39M | -15.42%-885.33M | -14.42%-403.71M | 5.24%-767.08M | ---352.82M | -81.44%-809.51M | 37.27%-446.16M | 0.33%-711.28M | 6.16%-372.76M | -30.22%-713.6M |
Operating expenses | -11.32%-449.39M | -15.42%-885.33M | -14.42%-403.71M | 5.24%-767.08M | -352.82M | -81.44%-809.51M | 37.27%-446.16M | 0.33%-711.28M | 6.16%-372.76M | -30.22%-713.6M |
Gross profit | 6.07%209.26M | 11.90%419.01M | 6.46%197.29M | 3.51%374.45M | 185.31M | 19.16%361.76M | -16.83%303.6M | 17.75%365.03M | 24.93%174.06M | 31.43%310M |
Selling expenses | -13.15%-49.88M | -21.74%-98.72M | -5.03%-44.09M | 2.49%-81.1M | ---41.98M | -10.80%-83.16M | 15.52%-75.06M | -19.13%-88.84M | -28.01%-42.73M | -76.94%-74.58M |
Administrative expenses | 1.79%-55.88M | -15.71%-133.23M | 6.83%-56.9M | -0.23%-115.15M | ---61.07M | -8.76%-114.88M | 14.98%-105.63M | -18.43%-124.24M | -31.10%-60.73M | -17.57%-104.9M |
Research and development expenses | -64.84%-450K | 42.80%-413K | 27.01%-273K | 65.72%-722K | ---374K | -397.87%-2.11M | 68.94%-423K | 37.84%-1.36M | 65.87%-559K | 12.47%-2.19M |
Revaluation surplus | ---- | 104.00%96.39M | 34.09%46.34M | 1,237.76%47.25M | --34.56M | 40.09%-4.15M | 78.31%-6.93M | ---31.97M | ---- | ---- |
-Changes in the fair value of other assets | ---- | 104.00%96.39M | 34.09%46.34M | 1,237.76%47.25M | --34.56M | 40.09%-4.15M | 78.31%-6.93M | ---31.97M | ---- | ---- |
Impairment and provision | 52.63%-1.32M | 7.20%-4.53M | -46.69%-2.79M | -26.02%-4.88M | ---1.9M | -84.46%-3.87M | -23.34%-2.1M | ---1.7M | ---- | ---- |
-Other impairment is provision | 52.63%-1.32M | 7.20%-4.53M | -46.69%-2.79M | -26.02%-4.88M | ---1.9M | -84.46%-3.87M | -23.34%-2.1M | ---1.7M | ---- | ---- |
Special items of operating profit | -21.78%5.96M | -14.06%12.83M | 15.29%7.61M | 106.07%14.93M | --6.6M | -56.56%7.25M | 17.06%16.68M | 1.19%14.25M | -47.51%4.66M | -11.39%14.08M |
Operating profit | -26.84%107.68M | 24.09%291.34M | 21.49%147.19M | 45.99%234.79M | 121.15M | 23.58%160.83M | -0.79%130.14M | -7.89%131.17M | 11.72%74.7M | 20.81%142.41M |
Financing income | ---- | 68.96%1.64M | ---- | -51.54%973K | --496K | 8.60%2.01M | -72.90%1.85M | 230.68%6.82M | 275.67%2.93M | -49.55%2.06M |
Financing cost | 1.73%-80.61M | -13.30%-163.14M | -11.34%-82.03M | -20.16%-143.99M | ---73.68M | -7.93%-119.83M | -7.79%-111.02M | -60.01%-103M | -57.72%-47.95M | -80.97%-64.37M |
Special items of earning before tax | ---3K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Earning before tax | -58.46%27.06M | 41.49%129.85M | 35.83%65.16M | 113.38%91.77M | 47.97M | 105.11%43.01M | -40.08%20.97M | -56.31%34.99M | -20.29%29.69M | -7.28%80.1M |
Tax | -161.10%-7.59M | -36.25%-20.02M | 19.93%-2.91M | -19.22%-14.69M | ---3.63M | -15.00%-12.32M | 45.46%-10.72M | 2.54%-19.65M | 21.03%-8.01M | 21.17%-20.16M |
After-tax profit from continuing operations | -68.71%19.48M | 42.49%109.83M | 40.40%62.25M | 151.19%77.08M | 44.34M | 199.30%30.69M | -33.18%10.25M | -74.40%15.35M | -20.02%21.68M | -1.44%59.94M |
Earning after tax | -68.71%19.48M | 42.49%109.83M | 40.40%62.25M | 151.19%77.08M | 44.34M | 199.30%30.69M | -33.18%10.25M | -74.40%15.35M | -20.02%21.68M | -1.44%59.94M |
Minority profit | -39.19%-206K | 77.06%-420K | 88.48%-148K | 46.54%-1.83M | ---1.29M | -64.03%-3.43M | -37.73%-2.09M | -14.16%-1.52M | -121.74%-1.02M | -66,300.00%-1.33M |
Profit attributable to shareholders | -68.45%19.69M | 39.72%110.25M | 36.77%62.4M | 131.34%78.91M | 45.63M | 176.41%34.11M | -26.81%12.34M | -72.48%16.86M | -17.65%22.7M | 0.74%61.27M |
Basic earnings per share | -79.24%0.0382 | 29.91%0.3023 | 28.94%0.184 | 118.09%0.2327 | 0.1427 | 176.42%0.1067 | -26.05%0.0386 | -71.00%0.0522 | 0.00%0.18 | |
Diluted earnings per share | -6.67%0.0364 | -58.07%0.0322 | 36.84%0.039 | -22.58%0.0768 | 0.0285 | 156.99%0.0992 | -26.05%0.0386 | -71.00%0.0522 | 0.00%0.18 | |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data